{"id": 199548902, "updated": "2022-02-05 06:37:29.318", "metadata": {"title": "Is papillary thyroid microcarcinoma a biologically different disease? A propensity score\u2010matched analysis", "authors": "[{\"middle\":[],\"last\":\"Hsu\",\"first\":\"Yi\\u2010Chiung\"},{\"middle\":[],\"last\":\"Lee\",\"first\":\"Jie\\u2010Jen\"},{\"middle\":[],\"last\":\"Chien\",\"first\":\"Ming\\u2010Nan\"},{\"middle\":[],\"last\":\"Chen\",\"first\":\"Ming\\u2010Jen\"},{\"middle\":[],\"last\":\"Leung\",\"first\":\"Ching\\u2010Hsiang\"},{\"middle\":[],\"last\":\"Cheng\",\"first\":\"Shih\\u2010Ping\"}]", "venue": null, "journal": "Journal of Surgical Oncology", "publication_date": {"year": 2019, "month": null, "day": null}, "abstract": "Papillary thyroid microcarcinoma exhibits an indolent clinical course and could be a candidate for active surveillance in the appropriate setting. It remains unknown whether papillary microcarcinoma is biologically different from larger papillary carcinoma >1\u2009cm.", "fields_of_study": "[\"Medicine\"]", "external_ids": {"arxiv": null, "mag": "2968533946", "acl": null, "pubmed": "31407354", "pubmedcentral": null, "dblp": null, "doi": "10.1002/jso.25670"}}, "content": {"source": {"pdf_hash": "439a294579b5bee95830ca9e19a321a1d5f7b667", "pdf_src": "Wiley", "pdf_uri": null, "oa_url_match": false, "oa_info": null}, "grobid": {"id": "884213d26f5a23a823185bcd758a03f0735e11b6", "type": "plain-text", "url": "s3://ai2-s2-pdf-extraction-prod/parse-results/s2orc_worker/439a294579b5bee95830ca9e19a321a1d5f7b667.txt", "contents": "\nIs papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis\n2019\n\nPhDYi-Chiung Hsu \nDepartment of Biomedical Sciences and Engineering\nNational Central University\nTaoyuan CityTaiwan\n\nMDJie-Jen Lee \nDepartment of Surgery\nMacKay Memorial Hospital and Mackay Medical College\nTaipeiTaiwan\n\nMDMing-Nan Chien \nDivision of Endocrinology and Metabolism\nDepartment of Internal Medicine\nMacKay Memorial Hospital and Mackay Medical College\nTaipeiTaiwan\n\nMDMing-Jen Chen \nDepartment of Surgery\nMacKay Memorial Hospital and Mackay Medical College\nTaipeiTaiwan\n\nDepartment of Pharmacology\nSchool of Medicine\nCollege of Medicine\nTaipei Medical University\nTaipeiTaiwan\n\nMDChing-Hsiang Leung \nDivision of Endocrinology and Metabolism\nDepartment of Internal Medicine\nMacKay Memorial Hospital and Mackay Medical College\nTaipeiTaiwan\n\nMD| Shih-Ping Cheng \nDepartment of Surgery\nMacKay Memorial Hospital and Mackay Medical College\nTaipeiTaiwan\n\nDepartment of Pharmacology\nSchool of Medicine\nCollege of Medicine\nTaipei Medical University\nTaipeiTaiwan\n\nIs papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis\n\nJ Surg Oncol\n120201910.1002/jso.25670Received: 1 March 2019 | Accepted: 4 August 2019R E S E A R C H A R T I C L E Correspondence Shih-Ping Cheng, MD, PhD, Department of Surgery, MacKay Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei 10449, Taiwan.\nBackground: Papillary thyroid microcarcinoma exhibits an indolent clinical course and could be a candidate for active surveillance in the appropriate setting. It remains unknown whether papillary microcarcinoma is biologically different from larger papillary carcinoma >1 cm. Methods: We analyzed clinicopathological information and transcriptome data of papillary thyroid cancer samples from The Cancer Genome Atlas. Propensity-score matching was used to construct a matched cohort consisting of 29 microcarcinomas and 58 carcinomas. Principal component analysis and unsupervised hierarchical cluster analysis were carried out to investigate the similarity of gene expression profiles. Results: After adjustment for differences in baseline clinicopathological and genetic factors, transcriptome could be grouped mainly on the basis of tumor class (BRAF-like vs RAS-like) and tumor size (microcarcinoma vs carcinoma). The gene set enrichment analysis showed that extracellular matrix-associated pathways were enriched in the MSigDB database. Conclusion: Papillary thyroid microcarcinomas display a distinct gene expression pattern different from the corresponding carcinomas. We hypothesize that tumor microenvironment may play a role in the microcarcinoma/carcinoma phenotypic divergence. K E Y W O R D S microcarcinoma, propensity score matching, thyroid carcinoma, transcriptome\n\n| INTRODUCTION\n\nPapillary thyroid microcarcinoma has been defined by the World Health Organization (WHO) classification of endocrine tumors as papillary cancer measuring 1 cm or less in diameter. 1 These tumors are typically not perceivable in clinical examination and have been increasingly diagnosed by high-resolution ultrasonography. The majority of patients with papillary thyroid microcarcinoma have an excellent prognosis. The overall survival of patients with microcarcinoma actually does not differ from the expected survival of the normal population. 2 In this context, active surveillance of papillary thyroid microcarcinoma (specifically, active treatment is delayed until the tumor shows signs of clinical progression to avoid adverse effects of treatment) has been advocated in properly selected patients. 3,4 Papillary thyroid microcarcinoma continues to be a subject of controversy in endocrine oncology. It is not uncommon to find occult cancer in autopsy patients who have no known history of thyroid pathology. 5 A group of pathologists proposed to use the term 'papillary microtumor' for a single focus of papillary carcinoma measuring <1 cm within the thyroid gland of an adult patient found incidentally at thyroidectomy. The consensus is known as the Porto proposal. 6 The suggested change in terminology is expected to reduce overtreatment and minimize the psychologic anxiety of patients. However, albeit rarely, the structural recurrent/persistent disease can still be seen in patients with microcarcinoma. 7 Riskstratified clinical frameworks for decision making have been developed to identify patients who are most likely to benefit from an upfront biopsy and surgical management. 8 Recently, we reported that tumor size is a major predictor for intermediate-risk pathologic features in differentiated thyroid cancer. 9 Interestingly, the receiver operating characteristic curve analysis suggested that the probability of presenting intermediaterisk pathologic features greatly increased when the tumor size was larger than or equal to 1.1 cm. This finding raised an important question as to whether microcarcinoma is biologically different from larger carcinoma. In the present study, we aimed to systemically compare the gene expression profiles between papillary thyroid microcarcinomas and carcinomas. To reduce confounding bias, propensity score model by matching the two patient cohorts was exploited for a meaningful comparison.\n\n\n| METHODS\n\n\n| Data query from the cancer genome atlas (TCGA)\n\nThe clinical information, DNA sequence/mutation data, and whole normalized level 3 RNAseq data were directly downloaded from\n\nThe Genomic Data Commons Data Portal (https://portal.gdc.\n\ncancer.gov/) and cross-validated with supplemental files of the initial TCGA_THCA global analysis. 10 The level of the gene expression was expressed as RNA-Seq by expectation maximization (RSEM) values. 11 According to the gene expression profile of a given tumor, samples could be further classified as BRAF-like (resembling those with BRAF V600E mutation) or RAS-like (resembling those with RAS mutant profiles). 10 Quantitative and qualitative variables were expressed as median (interquartile range) and frequency (percentage), respectively.\n\nComparisons between groups were analyzed with the chi-squared or Fisher's exact test for categorical variables. The Cochran-Armitage trend test was used to examine the significance of trends of ordinal variables. The Mann-Whitney U test was used to compare continuous variables. 12 2.2 | Propensity score matching A propensity score matching was calculated to take into account selection biases as well as confounding factors between the two groups as previously described. 13 After an initial comparison of papillary thyroid carcinomas and microcarcinomas, patients were matched in a 2:1 analysis with the nearest neighbor matching method. The 2:1 control-case ratio was chosen to improve precision and maintain statistical power without an increase in bias. 14 The propensity score was assessed using logistic regression including the following variables: age, sex, tumor subtype, multifocality, extrathyroidal extension, lymph node and distant metastasis, the American Joint Committee on Cancer stage, and driver mutations.\n\nAfter the matching process, the balance of the matched sample was checked using standardized differences with a match tolerance of 0.1.\n\n\n| Principal component analysis\n\nPrincipal component analysis (PCA) was used to visualize clusters of tumors on the basis of the variance-covariance structure of the gene expression profiles. The normalized data were log-transformed before the analysis. The eigenvalues and percentage of variability from the principal components were identified using selected discriminating genes. 15 The first two components that capture the greatest amount of variability were plotted against each other.\n\n\n| Hierarchical cluster analysis\n\nFor transcriptome classification, the gene expression data without PCA dimension reduction were subjected to Z-score transformation.\n\nUnsupervised hierarchical clustering was performed using average linkage as the agglomeration method. For average linkage, the distance between two clusters is the average of the pairwise distance between all pairs of individuals in the two clusters. Average linkage tends to produce clusters intermediate between single and complete linkage in terms of internal consistency. 16 Pearson correlation metric was employed as the similarity measure. The Pearson measure is scaleinvariant in comparison to the Euclidean measure and is most commonly used in clustering microarray expression data. 17 The Java\n\nTreeView software (https://bitbucket.org/TreeView3Dev/treeview3/) was applied to reveal the hierarchical groups.\n\n\n| Pathway analysis\n\nThe moderated t test and Benjamini-Hochberg correction were used to identify differentially expressed genes with a significant difference (P < .05) in expression levels between the two groups. The pathway enrichment analysis was carried out on differentially expressed genes using the Ingenuity Pathway Analysis (Qiagen, Redwood City, CA) and Molecular signatures database (MSigDB) C2 collection. 18 The MSigDB C2 collection includes gene sets from curated pathways databases such as Kyoto Encyclopedia of Genes and Genomes (KEGG) and those manually curated from the literature on gene expression. Significant pathways were defined as a false discovery rate less than 0.05.\n\n\n| RESULTS\n\nA total of 375 patients with papillary thyroid cancer who had sufficient clinicopathological and genetic information were included in the analysis. Among this cohort, 29 (8%) had a tumor size less than or equal to 1.0 cm, namely, microcarcinoma. As expected, patients with thyroid microcarcinoma had earlier disease stage (Table 1).\n\nNotably, the microcarcinomas included 17% tall cell variant, and extrathyroidal extension and lymph node metastasis were observed with a frequency of 21% and 34%, respectively.  (Table 1) \n\n\n| 1025\n\nThe main interest of this study was to identify biological differences between microcarcinomas and carcinomas. In total, 855 differentially expressed genes were retrieved on the basis of our predefined criteria.\n\nOverall, 32 genes belong to the list of genes in the Cancer Gene Census, 19 including CCND1, FGFR1, PDGFRA, and TGFBR2. Moreover, 106 (12%) were among the recurrence-associated genes that we previously reported. 20 There were 158 genes upregulated in carcinomas and 697 genes downregulated in carcinomas.\n\nWhen the downregulated and the upregulated genes were subjected to the pathway analysis separately, we found that upregulated genes in carcinomas were enriched in cancer-related pathways ( Table 2). The 697 genes downregulated in carcinomas were involved in G-protein coupled receptor signaling and cAMPmediated signaling (Table 3). It is noteworthy that there was a substantial overlap (40 out of 183) with downregulated genes participating in papillary thyroid cancer progression. 21 Altogether, compared with microcarcinomas, carcinomas lost some of the physiological regulatory functions during disease progression.\n\nThe gene set enrichment analysis was further performed using the MSigDB C2 collection. Significant modules containing differentially expressed genes were those encoding extracellular matrix and extracellular matrix-associated glycoproteins, collagens, and proteoglycans (Table 4)   However, the complexity of the disease progression process may conceal the delicate differences between microcarcinomas and carcinomas. 21 In agreement with the present observations, the frequency of BRAF V600E mutation was similar in patients with microcarcinomas and carcinomas. 24 Despite a smaller tumor size, BRAF V600E mutation in microcarcinomas still holds a prognostic role in terms of advanced stage and a higher likelihood for recurrence, 25,26 supporting that tumor biology is largely dictated by the oncogenic driver. The prevalence of TERT promoter mutations in microcarcinomas is generally low, 27 representing a late event of the disease.\n\nAlthough papillary thyroid microcarcinomas do not necessarily proceed to tumor growth, the expression of the sodium iodide symporter and thyroid peroxidase was generally lower in microcarcinomas. 28 In addition, microcarcinomas exhibited higher Bcl-2/ Bax ratio and lower expression of proliferation-related marker PCNA, indicating that there are differences in the balance between apoptosis and proliferation. 29 Japanese researchers demonstrated that a high Ki-67 labeling index was associated with progressive microcarcinomas. 30  been shown to be associated with invasion and metastasis in microcarcinomas. 31,32 In this study, we found that dermatopontin, a noncollagenous extracellular matrix protein, was downregulated in carcinomas. Dermatopontin has been shown to modulate cell cycle regulators to suppress thyroid cancer cell proliferation. 33 Furthermore, TGFBR2 expression was higher in microcarcinomas than carcinomas. This is in keeping with the experimental evidence that TGFBR2 overexpression may reduce tumorigenicity and metastatic potential of thyroid follicular cells. 34 Targeting transforming growth factor-\u03b2 signaling has emerged as a topic of great interest in the management of thyroid cancer. 35 The Gene Ontology analysis in this study suggests that biological differences involve leukocyte modulation. A desmoplastic stromal reaction can be found in larger microcarcinomas with invasion or lymph node metastases. 36 Using the neutrophil-to-lymphocyte ratio (NLR) as a surrogate marker of systemic inflammation, we reported that an increased NLR may predict an incomplete response to therapy in differentiated thyroid cancer. 37 Of interest, microcarcinoma aggressiveness is associated with specific subsets of tumorinfiltrating lymphocytes. Infiltration of FOXP3 + regulatory T cells may mediate peripheral immune tolerance and contribute to tumor progression in papillary thyroid microcarcinomas. 38 Collectively, the T A B L E 4 Molecular signatures database (MSigDB) C2 pathways associated with differentially expressed genes between papillary thyroid carcinomas and microcarcinomas\n\nMSigDB C2 Pathway FDR Genes\n\n\nM5884\n\nEnsemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens, and proteoglycans 1. 284E-5  SVEP1, MFAP4, SPARCL1, FGL1, COL28A1, MMRN1, PODN,  COL25A1, SMOC2, SSPO, FGL2, IGSF10, COL6A6, OGN, RSPO3,  CHAD, VIT, IGFBPL1, ADIPOQ, COL11A2, VTN, SNED1, IGFALS,  IGFBP3, SRGN, RELN, DCN, ZP2, DPT, ECM2, LAMA5, PCOLCE2   M5889 Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins 5. 743E-5  MMP21, F10, SVEP1, S100A2, MFAP4, C1QTNF3, SPARCL1,  C1QTNF7, CCL19, FGL1, CCL21, CXCL12, COL28A1, SHH,  MMRN1, LGALS13, CHRD, PODN, ADAM33, CPAMD8,  COL25A1, SMOC2, GDF1, GDF10, SSPO, FGL2, IGSF10, BMP5,  GPC3, ADAMTS16, COL6A6, NRTN, OGN, ANGPTL1, TGM4,  RSPO3, THPO, TLL1, C1QTNF9, SERPINA5, HGF, CHAD, PF4V1 differences between the two entities are also governed by the context of immune surveillance and escape.\n\nWe recognize some of the limitations of this study. First, the sample size is relatively small, particularly with regard to RAS-like tumors. Second, it is unknown whether microcarcinomas included in this study would remain quiescent or grow and spread without surgical resection. Incidental microcarcinomas have different characteristics and a lower recurrence rate than nonincidental microcarcinomas. 39 Nonetheless, given that a substantial portion of microcarcinomas had extrathyroidal extension or lymph node metastasis, it is likely that the majority of microcarcinomas in this study was not incidental. Finally, patient age has an impact on tumor gene expression. 11 It is well recognized that low-risk microcarcinomas are more likely to be indolent in elderly patients. 8 The median\n\nage of patients included in this study was in the early forties.\n\nConservative interpretation of these results is warranted.\n\nIn conclusion, after matching for clinicopathological and genetic factors, papillary thyroid microcarcinomas display a distinct gene expression pattern different from the corresponding carcinomas.\n\nLarger carcinomas have downregulation of physiological regulatory machinery, and differentially expressed genes are enriched in extracellular matrix-associated pathways. We hypothesize that tumor microenvironment may play a role in the microcarcinoma/ carcinoma phenotypic divergence. \n\n\nCONFLICT OF INTERESTS\n\nThe authors declare that there are no conflict of interests.\n\n\nDATA AVAILABILITY\n\nThe data used in this study are derived from deidentified data of The National Cancer Institute Genomic Data Commons. 40 The TCGA Publication Committee have not verified and are not responsible for the analytic or statistical methodology used, or the conclusions drawn from these data.\n\n\nORCID\n\nShih-Ping Cheng http://orcid.org/0000-0002-6301-5096\n\n\nNo telomerase reverse transcriptase (TERT) promoter mutation was observed in microcarcinomas, compared with a prevalence of 11% among carcinoma >1.0 cm. To provide visual representations of grouping on the basis of the gene expression, we used PCA to examine the relationship among tumors. As shown in Figure 1, PCA revealed a discrete grouping of the whole original cohort according to oncogenic drivers. This unsupervised view of the data indicates that tumor class was likely the largest source of variation in the distinction between gene expression profiles. There was no clear separation between microcarcinomas and carcinomas with tumor size >1 cm. Following propensity score matching, 58 carcinomas with tumor size >1.0 cm were selected. Matched pairs had similar clinicopathological and genetic background except for the tumor size\n\n\n. Overall, 63 (72%) were BRAF-like and 24 (28%) RAS-like. The resulting PCA showed BRAF-like tumors remained well separated from RAS-like tumors (Figure 2). Interestingly, microcarcinomas were largely separated from carcinomas after propensity matching. In addition to PCA, an unsupervised hierarchical cluster analysis was performed to categorize tumors into homogenous groups on the basis of the similarity of gene expression profiles. As shown in Figure 3, the dendrogram confirmed that transcriptome could be clearly grouped on the basis of tumor class (BRAF-like versus RAS-like). Furthermore, among BRAF-like tumors, the gene expression profiles of microcarcinomas were discretely separated from carcinomas. The distinction was somewhat less clear among RAS-like tumors.\n\n\n. Gene Ontology biological processes of differentially expressed genes were 'negative regulation of leukocyte tethering or rolling' (GO:1903237), 'negative regulation of leukocyte adhesion to vascular endothelial cell' (GO:1904995), 'positive regulation of Wnt signaling pathway, planar cell polarity pathway' (GO:2000096), 'regulation of leukocyte tethering or rolling' (GO:1903236), and 'negative regulation of cellular extravasation' (GO:0002692). Taken together, the transcriptome difference between microcarcinomas and carcinomas supports the involvement of the extracellular niche in tumor biology. 4 | DISCUSSION In this propensity-matched analysis of the TCGA_THCA data, we confirmed that tumor class (BRAF-like vs RAS-like) is the prime F I G U R E 1 Principal component analysis plots of the gene expression profiles of 375 papillary thyroid cancer from The Cancer Genome Atlas (TCGA) grouped by tumor class (A) or tumor size (B). [Color figure can be viewed at wileyonlinelibrary.com] F I G U R E 2 Principal component analysis plots of the gene expression profiles of 29 papillary thyroid microcarcinomas and propensity-matched 58 carcinomas from The Cancer Genome Atlas (TCGA) grouped by tumor class (A) or tumor size (B). [Color figure can be viewed at wileyonlinelibrary.com] determinant of the gene expression profile of papillary thyroid cancer. For microcarcinomas, the expression pattern similarly depends on the tumor class but clearly differs from that of larger carcinomas, especially among BRAF-like tumors. In this regard, our findings are in agreement with the WHO classification of endocrine tumors that microcarcinomas can be viewed as an indolent variant of papillary thyroid cancer. 1 Limited data are available concerning the molecular differences between microcarcinomas and carcinomas. A previous study that analyzed the gene expression profiles of 25 pairs of thyroid microcarcinomas and normal counterparts, as well as 11 pairs of carcinomas and normal counterparts, found that the gene expression profiles of microcarcinomas were not different from those of carcinomas. 22 Furthermore, there were no significant differences in the mRNA expression levels of pigment epithelium-derived factor, F I G U R E 3 Heatmap and unsupervised hierarchical clustering of gene expression profiles of 29 papillary thyroid microcarcinomas and propensity-matched 58 carcinomas from The Cancer Genome Atlas (TCGA). Case ID in black font color indicates BRAF-like, and a red font color indicates a RAS-like class. Case ID in a white background color indicates papillary thyroid cancer, and a yellow background color indicates microcarcinoma. [Color figure can be viewed at wileyonlinelibrary.com] T A B L E 2 Top ingenuity canonical pathways enriched by upregulated genes in papillary thyroid carcinomas compared with microcarcinomas\n\n\ncould be partially separated by PCA and the Pearson correlation measures. A plausible explanation is that the great heterogeneity of baseline characteristics may mask the less prominent patterns. Our propensity score matching approach is unique in focusing comparisons on the transcriptome of different tumor size while controlling for other clinicopathological factors. Larger carcinomas undoubtedly acquire and accumulate additional genetic alterations.\n\n\nThese observations are consistent with our results that some oncogenic regulators, such as CCND1, PIK3R2, and RRAS2, were upregulated in larger carcinomas. Overall, microcarcinomas do have a lower proliferative ability in comparison with larger carcinomas. Downregulation of physiological regulatory machinery is more pronounced than the upregulation of oncogenic pathways in our analysis. Considerable overlap with progression biomarkers is noted. These findings suggest that larger carcinomas proliferate possibly by inducing the repression of negative regulators. Reduction in the expression of cell adhesion molecules, particularly E-cadherin, has\n\nACKNOWLEDGMENT\nThis work was supported by research grants from the Ministry of Science and Technology of Taiwan 61;(MOST-107-2314-B-195-001-MY3) and MacKay Memorial Hospital (MMH-10813 and MMH-E-108-10).\n\n\nT A B L E 1 Clinicopathological parameters before and after propensity score matchingNote: Values are expressed as numbers with percentages or medians with interquartile ranges. Abbreviations: PTMC, papillary thyroid microcarcinoma; TCV, tall cell variant; TERTp, TERT promoter.Before matching \nAfter matching \n\nPTMC (n = 29) \nPTC (n = 346) \nP \nPTC (n = 58) \nP \n\nSubtype \n.189 \n1.000 \n\nClassic \n17 (59%) \n241 (70%) \n34 (59%) \n\nFV \n7 (24%) \n77 (22%) \n14 (24%) \n\nTCV \n5 (17%) \n23 (7%) \n10 (17%) \n\nOther \n0 (0%) \n5 (1%) \n\nSex \n.281 \n1.000 \n\nMale \n5 (17%) \n94 (27%) \n10 (17%) \n\nFemale \n24 (83%) \n252 (73%) \n48 (83%) \n\nAge \n43 (38 \u2212 52) \n47 (34 \u2212 59) \n.400 \n40 (31 \u2212 52) \n.278 \n\nTumor size \n1.0 (0.7 \u2212 1.0) \n2.6 (1.8 \u2212 4.0) \n<.001 \n2.1 (1.6 \u2212 3.0) \n<0.001 \n\nFocality a \n.084 \n.951 \n\nUnifocal \n11 (39%) \n190 (56%) \n22 (39%) \n\nMultifocal \n17 (61%) \n148 (44%) \n35 (61%) \n\nExtension a \n.303 \n1.000 \n\nNone \n23 (79%) \n240 (71%) \n46 (79%) \n\nMinimal (T3) \n6 (21%) \n86 (25%) \n12 (21%) \n\nAdvanced (T4) \n0 (0%) \n12 (4%) \n\nLymph node mets \n10 (34%) \n152 (44%) \n.324 \n20 (34%) \n1.000 \n\nDistant mets \n0 (0%) \n7 (2%) \n1.000 \n0 (0%) \n1.000 \n\nBRAF V600E \n17 (59%) \n205 (59%) \n.947 \n34 (59%) \n1.000 \n\nRAS mutation \n3 (10%) \n43 (12%) \n1.000 \n6 (10%) \n1.000 \n\nTERTp mutation \n0 (0%) \n38 (11%) \n.058 \n0 (0%) \n1.000 \n\nStage \n.027 \n.866 \n\nStage I \n23 (79%) \n191 (55%) \n45 (78%) \n\nStage II \n0 (0%) \n38 (11%) \n0 (0%) \n\nStage III \n4 (14%) \n73 (21%) \n9 (16%) \n\nStage IV \n2 (7%) \n44 (13%) \n4 (7%) \n\na \n\nMissing data. FV, follicular variant; PTC, papillary thyroid cancer >1 cm. \n\nHSU ET AL. \n\n\n\n\nAbbreviation: FDR, false discovery rate., \nVIT, IGFBPL1, COLEC12, ADIPOQ, BMP8A, COL11A2, VTN, \nPPBP, SNED1, IGFALS, IGFBP3, CSF3, SRGN, IL22, IL7, IL10, \nRELN, DCN, ZP2, CHRDL1, DPT, ECM2, LAMA5, MUC16, LGALS2, \nADAMTS10, FGFBP2, PCOLCE2, ANGPTL5 \n\nM3008 \nGenes encoding structural ECM glycoproteins \n4.811E-4 \nSVEP1, MFAP4, SPARCL1, FGL1, MMRN1, SMOC2, SSPO, FGL2, \nIGSF10, RSPO3, VIT, IGFBPL1, ADIPOQ, VTN, SNED1, IGFALS, \nIGFBP3, RELN, ZP2, DPT, ECM2, LAMA5, PCOLCE2 \n\n\n\nWHO Classification of Tumours of Endocrine Organs. R V Lloyd, R Y Osamura, G Kloppel, J Rosai, Lyon, France: IARC4th edLloyd RV, Osamura RY, Kloppel G, Rosai J, eds. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon, France: IARC; 2017.\n\nPapillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. I D Hay, M E Hutchinson, T Gonzalez-Losada, Surgery. 144Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;144:980-988.\n\nPapillary thyroid microcarcinoma: time to shift from surgery to active surveillance?. S Leboulleux, R M Tuttle, F Pacini, M Schlumberger, Lancet Diabetes Endocrinol. 4Leboulleux S, Tuttle RM, Pacini F, Schlumberger M. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol. 2016;4:933-942.\n\nConservative surveillance management of low-risk papillary thyroid microcarcinoma. A Miyauchi, Y Ito, Endocrinol Metab Clin North Am. 48Miyauchi A, Ito Y. Conservative surveillance management of low-risk papillary thyroid microcarcinoma. Endocrinol Metab Clin North Am. 2019;48:215-226.\n\nPrevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis. L Furuya-Kanamori, Kjl Bell, J Clark, P Glasziou, Sar Doi, J Clin Oncol. 34Furuya-Kanamori L, Bell KJL, Clark J, Glasziou P, Doi SAR. Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis. J Clin Oncol. 2016;34:3672-3679.\n\nRenaming papillary microcarcinoma of the thyroid gland: the Porto proposal. J Rosai, V A Livolsi, M Sobrinho-Simoes, E D Williams, Int J Surg Pathol. 11Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED. Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol. 2003;11:249-251.\n\nClinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma. M J Jeon, W G Kim, H Kwon, Eur J Endocrinol. 177Jeon MJ, Kim WG, Kwon H, et al. Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma. Eur J Endocrinol. 2017;177:25-31.\n\nA clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. J P Brito, Y Ito, A Miyauchi, R M Tuttle, Thyroid. 26Brito JP, Ito Y, Miyauchi A, Tuttle RM. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarci- noma. Thyroid. 2016;26:144-149.\n\nReconsideration of tumor size threshold for total thyroidectomy in differentiated thyroid cancer. S P Cheng, M N Chien, T Y Wang, J J Lee, C C Lee, C L Liu, Surgery. 164Cheng SP, Chien MN, Wang TY, Lee JJ, Lee CC, Liu CL. Reconsidera- tion of tumor size threshold for total thyroidectomy in differentiated thyroid cancer. Surgery. 2018;164:504-510.\n\nIntegrated genomic characterization of papillary thyroid carcinoma. N Agrawal, R Akbani, B Aksoy, Cell. 159Agrawal N, Akbani R, Aksoy B, et al. Integrated genomic character- ization of papillary thyroid carcinoma. Cell. 2014;159:676-690.\n\nInteraction of age at diagnosis with transcriptional profiling in papillary thyroid cancer. Y C Hsu, C L Liu, P S Yang, C H Tsai, J J Lee, S P Cheng, World J Surg. 40Hsu YC, Liu CL, Yang PS, Tsai CH, Lee JJ, Cheng SP. Interaction of age at diagnosis with transcriptional profiling in papillary thyroid cancer. World J Surg. 2016;40:2922-2929.\n\nHigh serum leptin level is associated with peripheral artery disease in geriatric individuals. T H Chen, C J Lee, J H Wang, B G Hsu, Int J of Gerontol. 12Chen TH, Lee CJ, Wang JH, Hsu BG. High serum leptin level is associated with peripheral artery disease in geriatric individuals. Int J of Gerontol. 2018;12:191-195.\n\nTranscriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation. M N Chien, P S Yang, Y C Hsu, T P Liu, J J Lee, S P Cheng, Head & Neck. 40Chien MN, Yang PS, Hsu YC, Liu TP, Lee JJ, Cheng SP. Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation. Head & Neck. 2018;40:2528-2537.\n\nStatistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. P C Austin, Am J Epidemiol. 172Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol. 2010;172:1092-1097.\n\nGene selection for microarray data analysis using principal component analysis. A Wang, E A Gehan, Stat Med. 24Wang A, Gehan EA. Gene selection for microarray data analysis using principal component analysis. Stat Med. 2005;24:2069-2087.\n\n. J Gollub, G Sherlock, Methods in enzymology. Methods Enzymol. 411Gollub J, Sherlock G. Methods in enzymology. Methods Enzymol. 2006;411:194-213.\n\nClustering approaches to identifying gene expression patterns from DNA microarray data. J H Do, D K Choi, Mol Cells. 25Do JH, Choi DK. Clustering approaches to identifying gene expression patterns from DNA microarray data. Mol Cells. 2008;25:279-288.\n\nLocal anesthetics induce apoptosis in human thyroid cancer cells through the mitogen-activated protein kinase pathway. Y C Chang, Y C Hsu, C L Liu, S Y Huang, M C Hu, S P Cheng, PLoS One. 989563Chang YC, Hsu YC, Liu CL, Huang SY, Hu MC, Cheng SP. Local anesthetics induce apoptosis in human thyroid cancer cells through the mitogen-activated protein kinase pathway. PLoS One. 2014;9:e89563.\n\nGenetic alterations in primary squamous cell carcinoma of the thyroid. T P Chu, W C Chen, T Y Wang, S P Cheng, Pathology. 48Chu TP, Chen WC, Wang TY, Cheng SP. Genetic alterations in primary squamous cell carcinoma of the thyroid. Pathology. 2016;48:523-525.\n\nRecurrenceassociated genes in papillary thyroid cancer: an analysis of data from The Cancer Genome Atlas. M N Chien, P S Yang, J J Lee, T Y Wang, Y C Hsu, S P Cheng, Surgery. 161Chien MN, Yang PS, Lee JJ, Wang TY, Hsu YC, Cheng SP. Recurrence- associated genes in papillary thyroid cancer: an analysis of data from The Cancer Genome Atlas. Surgery. 2017;161:1642-1650.\n\nOverexpression of teneurin transmembrane protein 1 is a potential marker of disease progression in papillary thyroid carcinoma. S P Cheng, M J Chen, M N Chien, C H Lin, J J Lee, C L Liu, Clin Exp Med. 17Cheng SP, Chen MJ, Chien MN, Lin CH, Lee JJ, Liu CL. Over- expression of teneurin transmembrane protein 1 is a potential marker of disease progression in papillary thyroid carcinoma. Clin Exp Med. 2017;17:555-564.\n\nComparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma. Y K Youn, H Kim, W Y Park, J Cancer Res Ther. 6Youn YK, Kim H, Park WY, et al. Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma. J Cancer Res Ther. 2010;6:452-457.\n\nClinicopathological features and prognosis of papillary thyroid microcarcinoma for surgery and relationships with the BRAFV600E mutational status and expression of angiogenic factors. C Shi, Y Guo, Y Lv, PLoS One. 1112167414Shi C, Guo Y, Lv Y. Clinicopathological features and prognosis of papillary thyroid microcarcinoma for surgery and relationships with the BRAFV600E mutational status and expression of angiogenic factors. PLoS One. 2016;11(12):e0167414.\n\nPapillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings. Y J Park, Y A Kim, Y J Lee, Head Neck. 32Park YJ, Kim YA, Lee YJ, et al. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings. Head Neck. 2010;32:38-45.\n\nBRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis. F Li, G Chen, C Sheng, Endocr Relat Cancer. 22Li F, Chen G, Sheng C, et al. BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis. Endocr Relat Cancer. 2015;22:159-168.\n\nBRAF(V600E) is correlated with recurrence of papillary thyroid microcarcinoma: a systematic review, multi-institutional primary data analysis, and meta-analysis. Y Chen, P M Sadow, H Suh, Thyroid. 26Chen Y, Sadow PM, Suh H, et al. BRAF(V600E) is correlated with recurrence of papillary thyroid microcarcinoma: a systematic review, multi-institutional primary data analysis, and meta-analysis. Thyroid. 2016;26:248-255.\n\nThe genetics of papillary microcarcinomas of the thyroid: diagnostic and prognostic implications. A C Rodrigues, G Penna, E Rodrigues, P Castro, M Sobrinho-Simoes, P Soares, Curr Genomics. 18Rodrigues AC, Penna G, Rodrigues E, Castro P, Sobrinho-Simoes M, Soares P. The genetics of papillary microcarcinomas of the thyroid: diagnostic and prognostic implications. Curr Genomics. 2017;18:244-254.\n\nBRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma. A U Bastos, G Oler, Bhn Nozima, R A Moys\u00e9s, J M Cerutti, Eur J Endocrinol. 173Bastos AU, Oler G, Nozima BHN, Moys\u00e9s RA, Cerutti JM. BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma. Eur J Endocrinol. 2015;173:525-540.\n\nApoptosis and proliferation related molecules (Bcl-2, Bax, p53, PCNA) in papillary microcarcinoma versus papillary carcinoma of the thyroid. D Cvejic, S Selemetjev, S Savin, I Paunovic, I Petrovic, S Tatic, Pathology. 40Cvejic D, Selemetjev S, Savin S, Paunovic I, Petrovic I, Tatic S. Apoptosis and proliferation related molecules (Bcl-2, Bax, p53, PCNA) in papillary microcarcinoma versus papillary carcinoma of the thyroid. Pathology. 2008;40:475-480.\n\nPathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance. M Hirokawa, T Kudo, H Ota, A Suzuki, A Miyauchi, Endocr J. 63Hirokawa M, Kudo T, Ota H, Suzuki A, Miyauchi A. Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance. Endocr J. 2016;63: 805-810.\n\nDifferential expression of dysadherin in papillary thyroid carcinoma and microcarcinoma: correlation with E-cadherin. A Batistatou, K Charalabopoulos, Y Nakanishi, Endocr Pathol. 19Batistatou A, Charalabopoulos K, Nakanishi Y, et al. Differential expression of dysadherin in papillary thyroid carcinoma and microcarci- noma: correlation with E-cadherin. Endocr Pathol. 2008;19:197-202.\n\nE-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma. M Nakamura, N Onoda, S Noda, Mol Clin Oncol. 2Nakamura M, Onoda N, Noda S, et al. E-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma. Mol Clin Oncol. 2014;2:226-232.\n\nDermatopontin inhibits papillary thyroid cancer cell proliferation through MYC repression. Y Guo, H Li, H Guan, Mol Cell Endocrinol. 480Guo Y, Li H, Guan H, et al. Dermatopontin inhibits papillary thyroid cancer cell proliferation through MYC repression. Mol Cell Endocrinol. 2019;480:122-132.\n\nOverexpression of transforming growth factor?-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells. A Turco, A Coppa, S Aloe, Int J Cancer. 80Turco A, Coppa A, Aloe S, et al. Overexpression of transforming growth factor?-type II receptor reduces tumorigenicity and metas- tastic potential of K-ras-transformed thyroid cells. Int J Cancer. 1999;80:85-91.\n\nDipeptidyl peptidase IV as a prognostic marker and therapeutic target in papillary thyroid carcinoma. J J Lee, T Y Wang, C L Liu, J Clin Endocrinol Metab. 102Lee JJ, Wang TY, Liu CL, et al. Dipeptidyl peptidase IV as a prognostic marker and therapeutic target in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2017;102:2930-2940.\n\nDesmoplastic stromal reaction in papillary thyroid microcarcinoma. O Koperek, R Asari, B Niederle, K Kaserer, Histopathology. 58Koperek O, Asari R, Niederle B, Kaserer K. Desmoplastic stromal reaction in papillary thyroid microcarcinoma. Histopathology. 2011;58:919-924.\n\nAn increased neutrophil-to-lymphocyte ratio predicts incomplete response to therapy in differentiated thyroid cancer. F Lee, P S Yang, M N Chien, J J Lee, C H Leung, S P Cheng, Int J Med Sci. 15Lee F, Yang PS, Chien MN, Lee JJ, Leung CH, Cheng SP. An increased neutrophil-to-lymphocyte ratio predicts incomplete response to therapy in differentiated thyroid cancer. Int J Med Sci. 2018;15:1757-1763.\n\nExpression of indoleamine 2,3-dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarcinoma. H S Ryu, Y S Park, H J Park, Thyroid. 24Ryu HS, Park YS, Park HJ, et al. Expression of indoleamine 2,3- dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarci- noma. Thyroid. 2014;24:1232-1240.\n\nDifferences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. H Mehanna, T Al-Maqbili, B Carter, J Clin Endocrinol Metab. 99Mehanna H, Al-Maqbili T, Carter B, et al. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab. 2014;99:2834-2843.\n\nThe National Cancer Institute Genomic Data Commons. DatasetThe National Cancer Institute Genomic Data Commons [Dataset].\n\nIs papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis. Y-C Hsu, J-J Lee, M-N Chien, M-J Chen, C-H Leung, S-P Cheng, J Surg Oncol. 120How to cite this articlehttps://portal.gdc.cancer.gov/. Accessed June 23, 2018. How to cite this article: Hsu Y-C, Lee J-J, Chien M-N, Chen M-J, Leung C-H, Cheng S-P. Is papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis. J Surg Oncol. 2019;120:1023-1030.\n\n. 10.1002/jso.25670https://doi.org/10.1002/jso.25670\n", "annotations": {"author": "[{\"start\":\"113\",\"end\":\"228\"},{\"start\":\"229\",\"end\":\"331\"},{\"start\":\"332\",\"end\":\"488\"},{\"start\":\"489\",\"end\":\"699\"},{\"start\":\"700\",\"end\":\"860\"},{\"start\":\"861\",\"end\":\"1075\"}]", "publisher": null, "author_last_name": "[{\"start\":\"126\",\"end\":\"129\"},{\"start\":\"239\",\"end\":\"242\"},{\"start\":\"343\",\"end\":\"348\"},{\"start\":\"500\",\"end\":\"504\"},{\"start\":\"715\",\"end\":\"720\"},{\"start\":\"875\",\"end\":\"880\"}]", "author_first_name": "[{\"start\":\"116\",\"end\":\"125\"},{\"start\":\"231\",\"end\":\"238\"},{\"start\":\"334\",\"end\":\"342\"},{\"start\":\"491\",\"end\":\"499\"},{\"start\":\"702\",\"end\":\"714\"},{\"start\":\"863\",\"end\":\"874\"}]", "author_affiliation": "[{\"start\":\"131\",\"end\":\"227\"},{\"start\":\"244\",\"end\":\"330\"},{\"start\":\"350\",\"end\":\"487\"},{\"start\":\"506\",\"end\":\"592\"},{\"start\":\"594\",\"end\":\"698\"},{\"start\":\"722\",\"end\":\"859\"},{\"start\":\"882\",\"end\":\"968\"},{\"start\":\"970\",\"end\":\"1074\"}]", "title": "[{\"start\":\"1\",\"end\":\"106\"},{\"start\":\"1076\",\"end\":\"1181\"}]", "venue": "[{\"start\":\"1183\",\"end\":\"1195\"}]", "abstract": "[{\"start\":\"1448\",\"end\":\"2829\"}]", "bib_ref": "[{\"start\":\"3027\",\"end\":\"3028\",\"attributes\":{\"ref_id\":\"b0\"}},{\"start\":\"3392\",\"end\":\"3393\",\"attributes\":{\"ref_id\":\"b1\"}},{\"start\":\"3651\",\"end\":\"3653\",\"attributes\":{\"ref_id\":\"b2\"}},{\"start\":\"3653\",\"end\":\"3654\",\"attributes\":{\"ref_id\":\"b3\"}},{\"start\":\"3861\",\"end\":\"3862\",\"attributes\":{\"ref_id\":\"b4\"}},{\"start\":\"4121\",\"end\":\"4122\",\"attributes\":{\"ref_id\":\"b5\"}},{\"start\":\"4364\",\"end\":\"4365\",\"attributes\":{\"ref_id\":\"b6\"}},{\"start\":\"4541\",\"end\":\"4542\",\"attributes\":{\"ref_id\":\"b7\"}},{\"start\":\"4678\",\"end\":\"4679\",\"attributes\":{\"ref_id\":\"b8\"}},{\"start\":\"5644\",\"end\":\"5646\",\"attributes\":{\"ref_id\":\"b9\"}},{\"start\":\"5748\",\"end\":\"5750\",\"attributes\":{\"ref_id\":\"b10\"}},{\"start\":\"5960\",\"end\":\"5962\",\"attributes\":{\"ref_id\":\"b9\"}},{\"start\":\"6371\",\"end\":\"6373\",\"attributes\":{\"ref_id\":\"b11\"}},{\"start\":\"6566\",\"end\":\"6568\",\"attributes\":{\"ref_id\":\"b12\"}},{\"start\":\"7640\",\"end\":\"7642\",\"attributes\":{\"ref_id\":\"b14\"}},{\"start\":\"8294\",\"end\":\"8296\",\"attributes\":{\"ref_id\":\"b15\"}},{\"start\":\"8509\",\"end\":\"8511\",\"attributes\":{\"ref_id\":\"b16\"}},{\"start\":\"9054\",\"end\":\"9056\",\"attributes\":{\"ref_id\":\"b17\"}},{\"start\":\"10163\",\"end\":\"10165\",\"attributes\":{\"ref_id\":\"b18\"}},{\"start\":\"10302\",\"end\":\"10304\",\"attributes\":{\"ref_id\":\"b19\"}},{\"start\":\"10879\",\"end\":\"10881\",\"attributes\":{\"ref_id\":\"b20\"}},{\"start\":\"11435\",\"end\":\"11437\",\"attributes\":{\"ref_id\":\"b20\"}},{\"start\":\"11580\",\"end\":\"11582\",\"attributes\":{\"ref_id\":\"b23\"}},{\"start\":\"11749\",\"end\":\"11752\",\"attributes\":{\"ref_id\":\"b24\"}},{\"start\":\"11752\",\"end\":\"11754\",\"attributes\":{\"ref_id\":\"b25\"}},{\"start\":\"11909\",\"end\":\"11911\",\"attributes\":{\"ref_id\":\"b26\"}},{\"start\":\"12151\",\"end\":\"12153\",\"attributes\":{\"ref_id\":\"b27\"}},{\"start\":\"12366\",\"end\":\"12368\",\"attributes\":{\"ref_id\":\"b28\"}},{\"start\":\"12485\",\"end\":\"12487\",\"attributes\":{\"ref_id\":\"b29\"}},{\"start\":\"12566\",\"end\":\"12569\",\"attributes\":{\"ref_id\":\"b30\"}},{\"start\":\"12569\",\"end\":\"12571\",\"attributes\":{\"ref_id\":\"b31\"}},{\"start\":\"12806\",\"end\":\"12808\",\"attributes\":{\"ref_id\":\"b32\"}},{\"start\":\"13044\",\"end\":\"13046\",\"attributes\":{\"ref_id\":\"b33\"}},{\"start\":\"13174\",\"end\":\"13176\",\"attributes\":{\"ref_id\":\"b34\"}},{\"start\":\"13396\",\"end\":\"13398\",\"attributes\":{\"ref_id\":\"b35\"}},{\"start\":\"13608\",\"end\":\"13610\",\"attributes\":{\"ref_id\":\"b36\"}},{\"start\":\"13881\",\"end\":\"13883\",\"attributes\":{\"ref_id\":\"b37\"}},{\"start\":\"15384\",\"end\":\"15386\",\"attributes\":{\"ref_id\":\"b38\"}},{\"start\":\"15652\",\"end\":\"15654\",\"attributes\":{\"ref_id\":\"b10\"}},{\"start\":\"15759\",\"end\":\"15760\",\"attributes\":{\"ref_id\":\"b7\"}},{\"start\":\"16608\",\"end\":\"16610\",\"attributes\":{\"ref_id\":\"b39\"}}]", "figure": "[{\"start\":\"16838\",\"end\":\"17680\",\"attributes\":{\"id\":\"fig_0\"}},{\"start\":\"17681\",\"end\":\"18459\",\"attributes\":{\"id\":\"fig_1\"}},{\"start\":\"18460\",\"end\":\"21311\",\"attributes\":{\"id\":\"fig_2\"}},{\"start\":\"21312\",\"end\":\"21769\",\"attributes\":{\"id\":\"fig_3\"}},{\"start\":\"21770\",\"end\":\"22423\",\"attributes\":{\"id\":\"fig_4\"}},{\"start\":\"22424\",\"end\":\"22628\",\"attributes\":{\"id\":\"fig_5\"}},{\"start\":\"22629\",\"end\":\"24191\",\"attributes\":{\"id\":\"tab_0\",\"type\":\"table\"}},{\"start\":\"24192\",\"end\":\"24667\",\"attributes\":{\"id\":\"tab_2\",\"type\":\"table\"}}]", "paragraph": "[{\"start\":\"2847\",\"end\":\"5295\"},{\"start\":\"5360\",\"end\":\"5484\"},{\"start\":\"5486\",\"end\":\"5543\"},{\"start\":\"5545\",\"end\":\"6090\"},{\"start\":\"6092\",\"end\":\"7118\"},{\"start\":\"7120\",\"end\":\"7255\"},{\"start\":\"7290\",\"end\":\"7748\"},{\"start\":\"7784\",\"end\":\"7916\"},{\"start\":\"7918\",\"end\":\"8520\"},{\"start\":\"8522\",\"end\":\"8634\"},{\"start\":\"8657\",\"end\":\"9330\"},{\"start\":\"9344\",\"end\":\"9676\"},{\"start\":\"9678\",\"end\":\"9866\"},{\"start\":\"9877\",\"end\":\"10088\"},{\"start\":\"10090\",\"end\":\"10394\"},{\"start\":\"10396\",\"end\":\"11015\"},{\"start\":\"11017\",\"end\":\"11953\"},{\"start\":\"11955\",\"end\":\"14068\"},{\"start\":\"14070\",\"end\":\"14097\"},{\"start\":\"14107\",\"end\":\"14980\"},{\"start\":\"14982\",\"end\":\"15771\"},{\"start\":\"15773\",\"end\":\"15837\"},{\"start\":\"15839\",\"end\":\"15897\"},{\"start\":\"15899\",\"end\":\"16095\"},{\"start\":\"16097\",\"end\":\"16382\"},{\"start\":\"16408\",\"end\":\"16468\"},{\"start\":\"16490\",\"end\":\"16775\"},{\"start\":\"16785\",\"end\":\"16837\"}]", "formula": null, "table_ref": "[{\"start\":\"9666\",\"end\":\"9675\"},{\"start\":\"9856\",\"end\":\"9865\"},{\"start\":\"10585\",\"end\":\"10592\"},{\"start\":\"10718\",\"end\":\"10726\"},{\"start\":\"11287\",\"end\":\"11296\"},{\"start\":\"14221\",\"end\":\"14459\"},{\"start\":\"14556\",\"end\":\"14875\"}]", "section_header": "[{\"start\":\"2831\",\"end\":\"2845\",\"attributes\":{\"n\":\"1\"}},{\"start\":\"5298\",\"end\":\"5307\",\"attributes\":{\"n\":\"2\"}},{\"start\":\"5310\",\"end\":\"5358\",\"attributes\":{\"n\":\"2.1\"}},{\"start\":\"7258\",\"end\":\"7288\",\"attributes\":{\"n\":\"2.3\"}},{\"start\":\"7751\",\"end\":\"7782\",\"attributes\":{\"n\":\"2.4\"}},{\"start\":\"8637\",\"end\":\"8655\",\"attributes\":{\"n\":\"2.5\"}},{\"start\":\"9333\",\"end\":\"9342\",\"attributes\":{\"n\":\"3\"}},{\"start\":\"9869\",\"end\":\"9875\"},{\"start\":\"14100\",\"end\":\"14105\"},{\"start\":\"16385\",\"end\":\"16406\"},{\"start\":\"16471\",\"end\":\"16488\"},{\"start\":\"16778\",\"end\":\"16783\"},{\"start\":\"22425\",\"end\":\"22439\"}]", "table": "[{\"start\":\"22909\",\"end\":\"24191\"},{\"start\":\"24234\",\"end\":\"24667\"}]", "figure_caption": "[{\"start\":\"16840\",\"end\":\"17680\"},{\"start\":\"17683\",\"end\":\"18459\"},{\"start\":\"18462\",\"end\":\"21311\"},{\"start\":\"21314\",\"end\":\"21769\"},{\"start\":\"21772\",\"end\":\"22423\"},{\"start\":\"22440\",\"end\":\"22628\"},{\"start\":\"22631\",\"end\":\"22909\"},{\"start\":\"24194\",\"end\":\"24234\"}]", "figure_ref": null, "bib_author_first_name": "[{\"start\":\"24720\",\"end\":\"24721\"},{\"start\":\"24722\",\"end\":\"24723\"},{\"start\":\"24731\",\"end\":\"24732\"},{\"start\":\"24733\",\"end\":\"24734\"},{\"start\":\"24744\",\"end\":\"24745\"},{\"start\":\"24755\",\"end\":\"24756\"},{\"start\":\"25006\",\"end\":\"25007\"},{\"start\":\"25008\",\"end\":\"25009\"},{\"start\":\"25015\",\"end\":\"25016\"},{\"start\":\"25017\",\"end\":\"25018\"},{\"start\":\"25031\",\"end\":\"25032\"},{\"start\":\"25310\",\"end\":\"25311\"},{\"start\":\"25324\",\"end\":\"25325\"},{\"start\":\"25326\",\"end\":\"25327\"},{\"start\":\"25336\",\"end\":\"25337\"},{\"start\":\"25346\",\"end\":\"25347\"},{\"start\":\"25655\",\"end\":\"25656\"},{\"start\":\"25667\",\"end\":\"25668\"},{\"start\":\"25958\",\"end\":\"25959\"},{\"start\":\"25977\",\"end\":\"25980\"},{\"start\":\"25987\",\"end\":\"25988\"},{\"start\":\"25996\",\"end\":\"25997\"},{\"start\":\"26008\",\"end\":\"26011\"},{\"start\":\"26300\",\"end\":\"26301\"},{\"start\":\"26309\",\"end\":\"26310\"},{\"start\":\"26311\",\"end\":\"26312\"},{\"start\":\"26322\",\"end\":\"26323\"},{\"start\":\"26341\",\"end\":\"26342\"},{\"start\":\"26343\",\"end\":\"26344\"},{\"start\":\"26641\",\"end\":\"26642\"},{\"start\":\"26643\",\"end\":\"26644\"},{\"start\":\"26651\",\"end\":\"26652\"},{\"start\":\"26653\",\"end\":\"26654\"},{\"start\":\"26660\",\"end\":\"26661\"},{\"start\":\"27023\",\"end\":\"27024\"},{\"start\":\"27025\",\"end\":\"27026\"},{\"start\":\"27034\",\"end\":\"27035\"},{\"start\":\"27041\",\"end\":\"27042\"},{\"start\":\"27053\",\"end\":\"27054\"},{\"start\":\"27055\",\"end\":\"27056\"},{\"start\":\"27411\",\"end\":\"27412\"},{\"start\":\"27413\",\"end\":\"27414\"},{\"start\":\"27422\",\"end\":\"27423\"},{\"start\":\"27424\",\"end\":\"27425\"},{\"start\":\"27433\",\"end\":\"27434\"},{\"start\":\"27435\",\"end\":\"27436\"},{\"start\":\"27443\",\"end\":\"27444\"},{\"start\":\"27445\",\"end\":\"27446\"},{\"start\":\"27452\",\"end\":\"27453\"},{\"start\":\"27454\",\"end\":\"27455\"},{\"start\":\"27461\",\"end\":\"27462\"},{\"start\":\"27463\",\"end\":\"27464\"},{\"start\":\"27731\",\"end\":\"27732\"},{\"start\":\"27742\",\"end\":\"27743\"},{\"start\":\"27752\",\"end\":\"27753\"},{\"start\":\"27994\",\"end\":\"27995\"},{\"start\":\"27996\",\"end\":\"27997\"},{\"start\":\"28003\",\"end\":\"28004\"},{\"start\":\"28005\",\"end\":\"28006\"},{\"start\":\"28012\",\"end\":\"28013\"},{\"start\":\"28014\",\"end\":\"28015\"},{\"start\":\"28022\",\"end\":\"28023\"},{\"start\":\"28024\",\"end\":\"28025\"},{\"start\":\"28032\",\"end\":\"28033\"},{\"start\":\"28034\",\"end\":\"28035\"},{\"start\":\"28041\",\"end\":\"28042\"},{\"start\":\"28043\",\"end\":\"28044\"},{\"start\":\"28341\",\"end\":\"28342\"},{\"start\":\"28343\",\"end\":\"28344\"},{\"start\":\"28351\",\"end\":\"28352\"},{\"start\":\"28353\",\"end\":\"28354\"},{\"start\":\"28360\",\"end\":\"28361\"},{\"start\":\"28362\",\"end\":\"28363\"},{\"start\":\"28370\",\"end\":\"28371\"},{\"start\":\"28372\",\"end\":\"28373\"},{\"start\":\"28679\",\"end\":\"28680\"},{\"start\":\"28681\",\"end\":\"28682\"},{\"start\":\"28690\",\"end\":\"28691\"},{\"start\":\"28692\",\"end\":\"28693\"},{\"start\":\"28700\",\"end\":\"28701\"},{\"start\":\"28702\",\"end\":\"28703\"},{\"start\":\"28709\",\"end\":\"28710\"},{\"start\":\"28711\",\"end\":\"28712\"},{\"start\":\"28718\",\"end\":\"28719\"},{\"start\":\"28720\",\"end\":\"28721\"},{\"start\":\"28727\",\"end\":\"28728\"},{\"start\":\"28729\",\"end\":\"28730\"},{\"start\":\"29117\",\"end\":\"29118\"},{\"start\":\"29119\",\"end\":\"29120\"},{\"start\":\"29441\",\"end\":\"29442\"},{\"start\":\"29449\",\"end\":\"29450\"},{\"start\":\"29451\",\"end\":\"29452\"},{\"start\":\"29602\",\"end\":\"29603\"},{\"start\":\"29612\",\"end\":\"29613\"},{\"start\":\"29836\",\"end\":\"29837\"},{\"start\":\"29838\",\"end\":\"29839\"},{\"start\":\"29844\",\"end\":\"29845\"},{\"start\":\"29846\",\"end\":\"29847\"},{\"start\":\"30119\",\"end\":\"30120\"},{\"start\":\"30121\",\"end\":\"30122\"},{\"start\":\"30130\",\"end\":\"30131\"},{\"start\":\"30132\",\"end\":\"30133\"},{\"start\":\"30139\",\"end\":\"30140\"},{\"start\":\"30141\",\"end\":\"30142\"},{\"start\":\"30148\",\"end\":\"30149\"},{\"start\":\"30150\",\"end\":\"30151\"},{\"start\":\"30159\",\"end\":\"30160\"},{\"start\":\"30161\",\"end\":\"30162\"},{\"start\":\"30167\",\"end\":\"30168\"},{\"start\":\"30169\",\"end\":\"30170\"},{\"start\":\"30463\",\"end\":\"30464\"},{\"start\":\"30465\",\"end\":\"30466\"},{\"start\":\"30472\",\"end\":\"30473\"},{\"start\":\"30474\",\"end\":\"30475\"},{\"start\":\"30482\",\"end\":\"30483\"},{\"start\":\"30484\",\"end\":\"30485\"},{\"start\":\"30492\",\"end\":\"30493\"},{\"start\":\"30494\",\"end\":\"30495\"},{\"start\":\"30758\",\"end\":\"30759\"},{\"start\":\"30760\",\"end\":\"30761\"},{\"start\":\"30769\",\"end\":\"30770\"},{\"start\":\"30771\",\"end\":\"30772\"},{\"start\":\"30779\",\"end\":\"30780\"},{\"start\":\"30781\",\"end\":\"30782\"},{\"start\":\"30788\",\"end\":\"30789\"},{\"start\":\"30790\",\"end\":\"30791\"},{\"start\":\"30798\",\"end\":\"30799\"},{\"start\":\"30800\",\"end\":\"30801\"},{\"start\":\"30807\",\"end\":\"30808\"},{\"start\":\"30809\",\"end\":\"30810\"},{\"start\":\"31150\",\"end\":\"31151\"},{\"start\":\"31152\",\"end\":\"31153\"},{\"start\":\"31161\",\"end\":\"31162\"},{\"start\":\"31163\",\"end\":\"31164\"},{\"start\":\"31171\",\"end\":\"31172\"},{\"start\":\"31173\",\"end\":\"31174\"},{\"start\":\"31182\",\"end\":\"31183\"},{\"start\":\"31184\",\"end\":\"31185\"},{\"start\":\"31191\",\"end\":\"31192\"},{\"start\":\"31193\",\"end\":\"31194\"},{\"start\":\"31200\",\"end\":\"31201\"},{\"start\":\"31202\",\"end\":\"31203\"},{\"start\":\"31558\",\"end\":\"31559\"},{\"start\":\"31560\",\"end\":\"31561\"},{\"start\":\"31568\",\"end\":\"31569\"},{\"start\":\"31575\",\"end\":\"31576\"},{\"start\":\"31577\",\"end\":\"31578\"},{\"start\":\"31975\",\"end\":\"31976\"},{\"start\":\"31982\",\"end\":\"31983\"},{\"start\":\"31989\",\"end\":\"31990\"},{\"start\":\"32420\",\"end\":\"32421\"},{\"start\":\"32422\",\"end\":\"32423\"},{\"start\":\"32430\",\"end\":\"32431\"},{\"start\":\"32432\",\"end\":\"32433\"},{\"start\":\"32439\",\"end\":\"32440\"},{\"start\":\"32441\",\"end\":\"32442\"},{\"start\":\"32761\",\"end\":\"32762\"},{\"start\":\"32767\",\"end\":\"32768\"},{\"start\":\"32775\",\"end\":\"32776\"},{\"start\":\"33111\",\"end\":\"33112\"},{\"start\":\"33119\",\"end\":\"33120\"},{\"start\":\"33121\",\"end\":\"33122\"},{\"start\":\"33130\",\"end\":\"33131\"},{\"start\":\"33467\",\"end\":\"33468\"},{\"start\":\"33469\",\"end\":\"33470\"},{\"start\":\"33482\",\"end\":\"33483\"},{\"start\":\"33491\",\"end\":\"33492\"},{\"start\":\"33504\",\"end\":\"33505\"},{\"start\":\"33514\",\"end\":\"33515\"},{\"start\":\"33533\",\"end\":\"33534\"},{\"start\":\"33900\",\"end\":\"33901\"},{\"start\":\"33902\",\"end\":\"33903\"},{\"start\":\"33912\",\"end\":\"33913\"},{\"start\":\"33920\",\"end\":\"33923\"},{\"start\":\"33932\",\"end\":\"33933\"},{\"start\":\"33934\",\"end\":\"33935\"},{\"start\":\"33944\",\"end\":\"33945\"},{\"start\":\"33946\",\"end\":\"33947\"},{\"start\":\"34344\",\"end\":\"34345\"},{\"start\":\"34354\",\"end\":\"34355\"},{\"start\":\"34368\",\"end\":\"34369\"},{\"start\":\"34377\",\"end\":\"34378\"},{\"start\":\"34389\",\"end\":\"34390\"},{\"start\":\"34401\",\"end\":\"34402\"},{\"start\":\"34778\",\"end\":\"34779\"},{\"start\":\"34790\",\"end\":\"34791\"},{\"start\":\"34798\",\"end\":\"34799\"},{\"start\":\"34805\",\"end\":\"34806\"},{\"start\":\"34815\",\"end\":\"34816\"},{\"start\":\"35154\",\"end\":\"35155\"},{\"start\":\"35168\",\"end\":\"35169\"},{\"start\":\"35187\",\"end\":\"35188\"},{\"start\":\"35553\",\"end\":\"35554\"},{\"start\":\"35565\",\"end\":\"35566\"},{\"start\":\"35574\",\"end\":\"35575\"},{\"start\":\"35889\",\"end\":\"35890\"},{\"start\":\"35896\",\"end\":\"35897\"},{\"start\":\"35902\",\"end\":\"35903\"},{\"start\":\"36241\",\"end\":\"36242\"},{\"start\":\"36250\",\"end\":\"36251\"},{\"start\":\"36259\",\"end\":\"36260\"},{\"start\":\"36598\",\"end\":\"36599\"},{\"start\":\"36600\",\"end\":\"36601\"},{\"start\":\"36607\",\"end\":\"36608\"},{\"start\":\"36609\",\"end\":\"36610\"},{\"start\":\"36617\",\"end\":\"36618\"},{\"start\":\"36619\",\"end\":\"36620\"},{\"start\":\"36901\",\"end\":\"36902\"},{\"start\":\"36912\",\"end\":\"36913\"},{\"start\":\"36921\",\"end\":\"36922\"},{\"start\":\"36933\",\"end\":\"36934\"},{\"start\":\"37224\",\"end\":\"37225\"},{\"start\":\"37231\",\"end\":\"37232\"},{\"start\":\"37233\",\"end\":\"37234\"},{\"start\":\"37241\",\"end\":\"37242\"},{\"start\":\"37243\",\"end\":\"37244\"},{\"start\":\"37252\",\"end\":\"37253\"},{\"start\":\"37254\",\"end\":\"37255\"},{\"start\":\"37261\",\"end\":\"37262\"},{\"start\":\"37263\",\"end\":\"37264\"},{\"start\":\"37272\",\"end\":\"37273\"},{\"start\":\"37274\",\"end\":\"37275\"},{\"start\":\"37672\",\"end\":\"37673\"},{\"start\":\"37674\",\"end\":\"37675\"},{\"start\":\"37681\",\"end\":\"37682\"},{\"start\":\"37683\",\"end\":\"37684\"},{\"start\":\"37691\",\"end\":\"37692\"},{\"start\":\"37693\",\"end\":\"37694\"},{\"start\":\"38142\",\"end\":\"38143\"},{\"start\":\"38153\",\"end\":\"38154\"},{\"start\":\"38167\",\"end\":\"38168\"},{\"start\":\"38720\",\"end\":\"38723\"},{\"start\":\"38729\",\"end\":\"38732\"},{\"start\":\"38738\",\"end\":\"38741\"},{\"start\":\"38749\",\"end\":\"38752\"},{\"start\":\"38759\",\"end\":\"38762\"},{\"start\":\"38770\",\"end\":\"38773\"}]", "bib_author_last_name": "[{\"start\":\"24724\",\"end\":\"24729\"},{\"start\":\"24735\",\"end\":\"24742\"},{\"start\":\"24746\",\"end\":\"24753\"},{\"start\":\"24757\",\"end\":\"24762\"},{\"start\":\"25010\",\"end\":\"25013\"},{\"start\":\"25019\",\"end\":\"25029\"},{\"start\":\"25033\",\"end\":\"25048\"},{\"start\":\"25312\",\"end\":\"25322\"},{\"start\":\"25328\",\"end\":\"25334\"},{\"start\":\"25338\",\"end\":\"25344\"},{\"start\":\"25348\",\"end\":\"25360\"},{\"start\":\"25657\",\"end\":\"25665\"},{\"start\":\"25669\",\"end\":\"25672\"},{\"start\":\"25960\",\"end\":\"25975\"},{\"start\":\"25981\",\"end\":\"25985\"},{\"start\":\"25989\",\"end\":\"25994\"},{\"start\":\"25998\",\"end\":\"26006\"},{\"start\":\"26012\",\"end\":\"26015\"},{\"start\":\"26302\",\"end\":\"26307\"},{\"start\":\"26313\",\"end\":\"26320\"},{\"start\":\"26324\",\"end\":\"26339\"},{\"start\":\"26345\",\"end\":\"26353\"},{\"start\":\"26645\",\"end\":\"26649\"},{\"start\":\"26655\",\"end\":\"26658\"},{\"start\":\"26662\",\"end\":\"26666\"},{\"start\":\"27027\",\"end\":\"27032\"},{\"start\":\"27036\",\"end\":\"27039\"},{\"start\":\"27043\",\"end\":\"27051\"},{\"start\":\"27057\",\"end\":\"27063\"},{\"start\":\"27415\",\"end\":\"27420\"},{\"start\":\"27426\",\"end\":\"27431\"},{\"start\":\"27437\",\"end\":\"27441\"},{\"start\":\"27447\",\"end\":\"27450\"},{\"start\":\"27456\",\"end\":\"27459\"},{\"start\":\"27465\",\"end\":\"27468\"},{\"start\":\"27733\",\"end\":\"27740\"},{\"start\":\"27744\",\"end\":\"27750\"},{\"start\":\"27754\",\"end\":\"27759\"},{\"start\":\"27998\",\"end\":\"28001\"},{\"start\":\"28007\",\"end\":\"28010\"},{\"start\":\"28016\",\"end\":\"28020\"},{\"start\":\"28026\",\"end\":\"28030\"},{\"start\":\"28036\",\"end\":\"28039\"},{\"start\":\"28045\",\"end\":\"28050\"},{\"start\":\"28345\",\"end\":\"28349\"},{\"start\":\"28355\",\"end\":\"28358\"},{\"start\":\"28364\",\"end\":\"28368\"},{\"start\":\"28374\",\"end\":\"28377\"},{\"start\":\"28683\",\"end\":\"28688\"},{\"start\":\"28694\",\"end\":\"28698\"},{\"start\":\"28704\",\"end\":\"28707\"},{\"start\":\"28713\",\"end\":\"28716\"},{\"start\":\"28722\",\"end\":\"28725\"},{\"start\":\"28731\",\"end\":\"28736\"},{\"start\":\"29121\",\"end\":\"29127\"},{\"start\":\"29443\",\"end\":\"29447\"},{\"start\":\"29453\",\"end\":\"29458\"},{\"start\":\"29604\",\"end\":\"29610\"},{\"start\":\"29614\",\"end\":\"29622\"},{\"start\":\"29840\",\"end\":\"29842\"},{\"start\":\"29848\",\"end\":\"29852\"},{\"start\":\"30123\",\"end\":\"30128\"},{\"start\":\"30134\",\"end\":\"30137\"},{\"start\":\"30143\",\"end\":\"30146\"},{\"start\":\"30152\",\"end\":\"30157\"},{\"start\":\"30163\",\"end\":\"30165\"},{\"start\":\"30171\",\"end\":\"30176\"},{\"start\":\"30467\",\"end\":\"30470\"},{\"start\":\"30476\",\"end\":\"30480\"},{\"start\":\"30486\",\"end\":\"30490\"},{\"start\":\"30496\",\"end\":\"30501\"},{\"start\":\"30762\",\"end\":\"30767\"},{\"start\":\"30773\",\"end\":\"30777\"},{\"start\":\"30783\",\"end\":\"30786\"},{\"start\":\"30792\",\"end\":\"30796\"},{\"start\":\"30802\",\"end\":\"30805\"},{\"start\":\"30811\",\"end\":\"30816\"},{\"start\":\"31154\",\"end\":\"31159\"},{\"start\":\"31165\",\"end\":\"31169\"},{\"start\":\"31175\",\"end\":\"31180\"},{\"start\":\"31186\",\"end\":\"31189\"},{\"start\":\"31195\",\"end\":\"31198\"},{\"start\":\"31204\",\"end\":\"31207\"},{\"start\":\"31562\",\"end\":\"31566\"},{\"start\":\"31570\",\"end\":\"31573\"},{\"start\":\"31579\",\"end\":\"31583\"},{\"start\":\"31977\",\"end\":\"31980\"},{\"start\":\"31984\",\"end\":\"31987\"},{\"start\":\"31991\",\"end\":\"31993\"},{\"start\":\"32424\",\"end\":\"32428\"},{\"start\":\"32434\",\"end\":\"32437\"},{\"start\":\"32443\",\"end\":\"32446\"},{\"start\":\"32763\",\"end\":\"32765\"},{\"start\":\"32769\",\"end\":\"32773\"},{\"start\":\"32777\",\"end\":\"32782\"},{\"start\":\"33113\",\"end\":\"33117\"},{\"start\":\"33123\",\"end\":\"33128\"},{\"start\":\"33132\",\"end\":\"33135\"},{\"start\":\"33471\",\"end\":\"33480\"},{\"start\":\"33484\",\"end\":\"33489\"},{\"start\":\"33493\",\"end\":\"33502\"},{\"start\":\"33506\",\"end\":\"33512\"},{\"start\":\"33516\",\"end\":\"33531\"},{\"start\":\"33535\",\"end\":\"33541\"},{\"start\":\"33904\",\"end\":\"33910\"},{\"start\":\"33914\",\"end\":\"33918\"},{\"start\":\"33924\",\"end\":\"33930\"},{\"start\":\"33936\",\"end\":\"33942\"},{\"start\":\"33948\",\"end\":\"33955\"},{\"start\":\"34346\",\"end\":\"34352\"},{\"start\":\"34356\",\"end\":\"34366\"},{\"start\":\"34370\",\"end\":\"34375\"},{\"start\":\"34379\",\"end\":\"34387\"},{\"start\":\"34391\",\"end\":\"34399\"},{\"start\":\"34403\",\"end\":\"34408\"},{\"start\":\"34780\",\"end\":\"34788\"},{\"start\":\"34792\",\"end\":\"34796\"},{\"start\":\"34800\",\"end\":\"34803\"},{\"start\":\"34807\",\"end\":\"34813\"},{\"start\":\"34817\",\"end\":\"34825\"},{\"start\":\"35156\",\"end\":\"35166\"},{\"start\":\"35170\",\"end\":\"35185\"},{\"start\":\"35189\",\"end\":\"35198\"},{\"start\":\"35555\",\"end\":\"35563\"},{\"start\":\"35567\",\"end\":\"35572\"},{\"start\":\"35576\",\"end\":\"35580\"},{\"start\":\"35891\",\"end\":\"35894\"},{\"start\":\"35898\",\"end\":\"35900\"},{\"start\":\"35904\",\"end\":\"35908\"},{\"start\":\"36243\",\"end\":\"36248\"},{\"start\":\"36252\",\"end\":\"36257\"},{\"start\":\"36261\",\"end\":\"36265\"},{\"start\":\"36602\",\"end\":\"36605\"},{\"start\":\"36611\",\"end\":\"36615\"},{\"start\":\"36621\",\"end\":\"36624\"},{\"start\":\"36903\",\"end\":\"36910\"},{\"start\":\"36914\",\"end\":\"36919\"},{\"start\":\"36923\",\"end\":\"36931\"},{\"start\":\"36935\",\"end\":\"36942\"},{\"start\":\"37226\",\"end\":\"37229\"},{\"start\":\"37235\",\"end\":\"37239\"},{\"start\":\"37245\",\"end\":\"37250\"},{\"start\":\"37256\",\"end\":\"37259\"},{\"start\":\"37265\",\"end\":\"37270\"},{\"start\":\"37276\",\"end\":\"37281\"},{\"start\":\"37676\",\"end\":\"37679\"},{\"start\":\"37685\",\"end\":\"37689\"},{\"start\":\"37695\",\"end\":\"37699\"},{\"start\":\"38144\",\"end\":\"38151\"},{\"start\":\"38155\",\"end\":\"38165\"},{\"start\":\"38169\",\"end\":\"38175\"},{\"start\":\"38724\",\"end\":\"38727\"},{\"start\":\"38733\",\"end\":\"38736\"},{\"start\":\"38742\",\"end\":\"38747\"},{\"start\":\"38753\",\"end\":\"38757\"},{\"start\":\"38763\",\"end\":\"38768\"},{\"start\":\"38774\",\"end\":\"38779\"}]", "bib_entry": "[{\"start\":\"24669\",\"end\":\"24919\",\"attributes\":{\"id\":\"b0\"}},{\"start\":\"24921\",\"end\":\"25222\",\"attributes\":{\"matched_paper_id\":\"44972450\",\"id\":\"b1\"}},{\"start\":\"25224\",\"end\":\"25570\",\"attributes\":{\"matched_paper_id\":\"4970056\",\"id\":\"b2\"}},{\"start\":\"25572\",\"end\":\"25858\",\"attributes\":{\"matched_paper_id\":\"73416814\",\"id\":\"b3\"}},{\"start\":\"25860\",\"end\":\"26222\",\"attributes\":{\"matched_paper_id\":\"22456749\",\"id\":\"b4\"}},{\"start\":\"26224\",\"end\":\"26540\",\"attributes\":{\"matched_paper_id\":\"45625033\",\"id\":\"b5\"}},{\"start\":\"26542\",\"end\":\"26853\",\"attributes\":{\"matched_paper_id\":\"22308649\",\"id\":\"b6\"}},{\"start\":\"26855\",\"end\":\"27311\",\"attributes\":{\"matched_paper_id\":\"7447746\",\"id\":\"b7\"}},{\"start\":\"27313\",\"end\":\"27661\",\"attributes\":{\"matched_paper_id\":\"44088635\",\"id\":\"b8\"}},{\"start\":\"27663\",\"end\":\"27900\",\"attributes\":{\"matched_paper_id\":\"6709043\",\"id\":\"b9\"}},{\"start\":\"27902\",\"end\":\"28244\",\"attributes\":{\"matched_paper_id\":\"20576748\",\"id\":\"b10\"}},{\"start\":\"28246\",\"end\":\"28564\",\"attributes\":{\"matched_paper_id\":\"79656454\",\"id\":\"b11\"}},{\"start\":\"28566\",\"end\":\"28950\",\"attributes\":{\"matched_paper_id\":\"51972486\",\"id\":\"b12\"}},{\"start\":\"28952\",\"end\":\"29359\",\"attributes\":{\"matched_paper_id\":\"8621537\",\"id\":\"b13\"}},{\"start\":\"29361\",\"end\":\"29598\",\"attributes\":{\"matched_paper_id\":\"25639353\",\"id\":\"b14\"}},{\"start\":\"29600\",\"end\":\"29746\",\"attributes\":{\"id\":\"b15\"}},{\"start\":\"29748\",\"end\":\"29998\",\"attributes\":{\"matched_paper_id\":\"24375313\",\"id\":\"b16\"}},{\"start\":\"30000\",\"end\":\"30390\",\"attributes\":{\"matched_paper_id\":\"17539735\",\"id\":\"b17\"}},{\"start\":\"30392\",\"end\":\"30650\",\"attributes\":{\"matched_paper_id\":\"38509886\",\"id\":\"b18\"}},{\"start\":\"30652\",\"end\":\"31020\",\"attributes\":{\"id\":\"b19\"}},{\"start\":\"31022\",\"end\":\"31438\",\"attributes\":{\"matched_paper_id\":\"22266799\",\"id\":\"b20\"}},{\"start\":\"31440\",\"end\":\"31789\",\"attributes\":{\"matched_paper_id\":\"14460987\",\"id\":\"b21\"}},{\"start\":\"31791\",\"end\":\"32250\",\"attributes\":{\"matched_paper_id\":\"7481255\",\"id\":\"b22\"}},{\"start\":\"32252\",\"end\":\"32686\",\"attributes\":{\"matched_paper_id\":\"205856379\",\"id\":\"b23\"}},{\"start\":\"32688\",\"end\":\"32947\",\"attributes\":{\"matched_paper_id\":\"875574\",\"id\":\"b24\"}},{\"start\":\"32949\",\"end\":\"33367\",\"attributes\":{\"matched_paper_id\":\"31822726\",\"id\":\"b25\"}},{\"start\":\"33369\",\"end\":\"33764\",\"attributes\":{\"matched_paper_id\":\"36099075\",\"id\":\"b26\"}},{\"start\":\"33766\",\"end\":\"34201\",\"attributes\":{\"matched_paper_id\":\"207131238\",\"id\":\"b27\"}},{\"start\":\"34203\",\"end\":\"34657\",\"attributes\":{\"matched_paper_id\":\"43825579\",\"id\":\"b28\"}},{\"start\":\"34659\",\"end\":\"35034\",\"attributes\":{\"matched_paper_id\":\"31213127\",\"id\":\"b29\"}},{\"start\":\"35036\",\"end\":\"35421\",\"attributes\":{\"matched_paper_id\":\"21952186\",\"id\":\"b30\"}},{\"start\":\"35423\",\"end\":\"35796\",\"attributes\":{\"matched_paper_id\":\"37152054\",\"id\":\"b31\"}},{\"start\":\"35798\",\"end\":\"36091\",\"attributes\":{\"matched_paper_id\":\"53222074\",\"id\":\"b32\"}},{\"start\":\"36093\",\"end\":\"36494\",\"attributes\":{\"matched_paper_id\":\"13550226\",\"id\":\"b33\"}},{\"start\":\"36496\",\"end\":\"36832\",\"attributes\":{\"matched_paper_id\":\"3753519\",\"id\":\"b34\"}},{\"start\":\"36834\",\"end\":\"37104\",\"attributes\":{\"matched_paper_id\":\"4771018\",\"id\":\"b35\"}},{\"start\":\"37106\",\"end\":\"37505\",\"attributes\":{\"matched_paper_id\":\"56812630\",\"id\":\"b36\"}},{\"start\":\"37507\",\"end\":\"37940\",\"attributes\":{\"matched_paper_id\":\"206273330\",\"id\":\"b37\"}},{\"start\":\"37942\",\"end\":\"38489\",\"attributes\":{\"matched_paper_id\":\"35330615\",\"id\":\"b38\"}},{\"start\":\"38491\",\"end\":\"38611\",\"attributes\":{\"id\":\"b39\"}},{\"start\":\"38613\",\"end\":\"39105\",\"attributes\":{\"matched_paper_id\":\"199548902\",\"id\":\"b40\"}},{\"start\":\"39107\",\"end\":\"39159\",\"attributes\":{\"id\":\"b41\",\"doi\":\"10.1002/jso.25670\"}}]", "bib_title": "[{\"start\":\"24921\",\"end\":\"25004\"},{\"start\":\"25224\",\"end\":\"25308\"},{\"start\":\"25572\",\"end\":\"25653\"},{\"start\":\"25860\",\"end\":\"25956\"},{\"start\":\"26224\",\"end\":\"26298\"},{\"start\":\"26542\",\"end\":\"26639\"},{\"start\":\"26855\",\"end\":\"27021\"},{\"start\":\"27313\",\"end\":\"27409\"},{\"start\":\"27663\",\"end\":\"27729\"},{\"start\":\"27902\",\"end\":\"27992\"},{\"start\":\"28246\",\"end\":\"28339\"},{\"start\":\"28566\",\"end\":\"28677\"},{\"start\":\"28952\",\"end\":\"29115\"},{\"start\":\"29361\",\"end\":\"29439\"},{\"start\":\"29748\",\"end\":\"29834\"},{\"start\":\"30000\",\"end\":\"30117\"},{\"start\":\"30392\",\"end\":\"30461\"},{\"start\":\"30652\",\"end\":\"30756\"},{\"start\":\"31022\",\"end\":\"31148\"},{\"start\":\"31440\",\"end\":\"31556\"},{\"start\":\"31791\",\"end\":\"31973\"},{\"start\":\"32252\",\"end\":\"32418\"},{\"start\":\"32688\",\"end\":\"32759\"},{\"start\":\"32949\",\"end\":\"33109\"},{\"start\":\"33369\",\"end\":\"33465\"},{\"start\":\"33766\",\"end\":\"33898\"},{\"start\":\"34203\",\"end\":\"34342\"},{\"start\":\"34659\",\"end\":\"34776\"},{\"start\":\"35036\",\"end\":\"35152\"},{\"start\":\"35423\",\"end\":\"35551\"},{\"start\":\"35798\",\"end\":\"35887\"},{\"start\":\"36093\",\"end\":\"36239\"},{\"start\":\"36496\",\"end\":\"36596\"},{\"start\":\"36834\",\"end\":\"36899\"},{\"start\":\"37106\",\"end\":\"37222\"},{\"start\":\"37507\",\"end\":\"37670\"},{\"start\":\"37942\",\"end\":\"38140\"},{\"start\":\"38613\",\"end\":\"38718\"}]", "bib_author": "[{\"start\":\"24720\",\"end\":\"24731\"},{\"start\":\"24731\",\"end\":\"24744\"},{\"start\":\"24744\",\"end\":\"24755\"},{\"start\":\"24755\",\"end\":\"24764\"},{\"start\":\"25006\",\"end\":\"25015\"},{\"start\":\"25015\",\"end\":\"25031\"},{\"start\":\"25031\",\"end\":\"25050\"},{\"start\":\"25310\",\"end\":\"25324\"},{\"start\":\"25324\",\"end\":\"25336\"},{\"start\":\"25336\",\"end\":\"25346\"},{\"start\":\"25346\",\"end\":\"25362\"},{\"start\":\"25655\",\"end\":\"25667\"},{\"start\":\"25667\",\"end\":\"25674\"},{\"start\":\"25958\",\"end\":\"25977\"},{\"start\":\"25977\",\"end\":\"25987\"},{\"start\":\"25987\",\"end\":\"25996\"},{\"start\":\"25996\",\"end\":\"26008\"},{\"start\":\"26008\",\"end\":\"26017\"},{\"start\":\"26300\",\"end\":\"26309\"},{\"start\":\"26309\",\"end\":\"26322\"},{\"start\":\"26322\",\"end\":\"26341\"},{\"start\":\"26341\",\"end\":\"26355\"},{\"start\":\"26641\",\"end\":\"26651\"},{\"start\":\"26651\",\"end\":\"26660\"},{\"start\":\"26660\",\"end\":\"26668\"},{\"start\":\"27023\",\"end\":\"27034\"},{\"start\":\"27034\",\"end\":\"27041\"},{\"start\":\"27041\",\"end\":\"27053\"},{\"start\":\"27053\",\"end\":\"27065\"},{\"start\":\"27411\",\"end\":\"27422\"},{\"start\":\"27422\",\"end\":\"27433\"},{\"start\":\"27433\",\"end\":\"27443\"},{\"start\":\"27443\",\"end\":\"27452\"},{\"start\":\"27452\",\"end\":\"27461\"},{\"start\":\"27461\",\"end\":\"27470\"},{\"start\":\"27731\",\"end\":\"27742\"},{\"start\":\"27742\",\"end\":\"27752\"},{\"start\":\"27752\",\"end\":\"27761\"},{\"start\":\"27994\",\"end\":\"28003\"},{\"start\":\"28003\",\"end\":\"28012\"},{\"start\":\"28012\",\"end\":\"28022\"},{\"start\":\"28022\",\"end\":\"28032\"},{\"start\":\"28032\",\"end\":\"28041\"},{\"start\":\"28041\",\"end\":\"28052\"},{\"start\":\"28341\",\"end\":\"28351\"},{\"start\":\"28351\",\"end\":\"28360\"},{\"start\":\"28360\",\"end\":\"28370\"},{\"start\":\"28370\",\"end\":\"28379\"},{\"start\":\"28679\",\"end\":\"28690\"},{\"start\":\"28690\",\"end\":\"28700\"},{\"start\":\"28700\",\"end\":\"28709\"},{\"start\":\"28709\",\"end\":\"28718\"},{\"start\":\"28718\",\"end\":\"28727\"},{\"start\":\"28727\",\"end\":\"28738\"},{\"start\":\"29117\",\"end\":\"29129\"},{\"start\":\"29441\",\"end\":\"29449\"},{\"start\":\"29449\",\"end\":\"29460\"},{\"start\":\"29602\",\"end\":\"29612\"},{\"start\":\"29612\",\"end\":\"29624\"},{\"start\":\"29836\",\"end\":\"29844\"},{\"start\":\"29844\",\"end\":\"29854\"},{\"start\":\"30119\",\"end\":\"30130\"},{\"start\":\"30130\",\"end\":\"30139\"},{\"start\":\"30139\",\"end\":\"30148\"},{\"start\":\"30148\",\"end\":\"30159\"},{\"start\":\"30159\",\"end\":\"30167\"},{\"start\":\"30167\",\"end\":\"30178\"},{\"start\":\"30463\",\"end\":\"30472\"},{\"start\":\"30472\",\"end\":\"30482\"},{\"start\":\"30482\",\"end\":\"30492\"},{\"start\":\"30492\",\"end\":\"30503\"},{\"start\":\"30758\",\"end\":\"30769\"},{\"start\":\"30769\",\"end\":\"30779\"},{\"start\":\"30779\",\"end\":\"30788\"},{\"start\":\"30788\",\"end\":\"30798\"},{\"start\":\"30798\",\"end\":\"30807\"},{\"start\":\"30807\",\"end\":\"30818\"},{\"start\":\"31150\",\"end\":\"31161\"},{\"start\":\"31161\",\"end\":\"31171\"},{\"start\":\"31171\",\"end\":\"31182\"},{\"start\":\"31182\",\"end\":\"31191\"},{\"start\":\"31191\",\"end\":\"31200\"},{\"start\":\"31200\",\"end\":\"31209\"},{\"start\":\"31558\",\"end\":\"31568\"},{\"start\":\"31568\",\"end\":\"31575\"},{\"start\":\"31575\",\"end\":\"31585\"},{\"start\":\"31975\",\"end\":\"31982\"},{\"start\":\"31982\",\"end\":\"31989\"},{\"start\":\"31989\",\"end\":\"31995\"},{\"start\":\"32420\",\"end\":\"32430\"},{\"start\":\"32430\",\"end\":\"32439\"},{\"start\":\"32439\",\"end\":\"32448\"},{\"start\":\"32761\",\"end\":\"32767\"},{\"start\":\"32767\",\"end\":\"32775\"},{\"start\":\"32775\",\"end\":\"32784\"},{\"start\":\"33111\",\"end\":\"33119\"},{\"start\":\"33119\",\"end\":\"33130\"},{\"start\":\"33130\",\"end\":\"33137\"},{\"start\":\"33467\",\"end\":\"33482\"},{\"start\":\"33482\",\"end\":\"33491\"},{\"start\":\"33491\",\"end\":\"33504\"},{\"start\":\"33504\",\"end\":\"33514\"},{\"start\":\"33514\",\"end\":\"33533\"},{\"start\":\"33533\",\"end\":\"33543\"},{\"start\":\"33900\",\"end\":\"33912\"},{\"start\":\"33912\",\"end\":\"33920\"},{\"start\":\"33920\",\"end\":\"33932\"},{\"start\":\"33932\",\"end\":\"33944\"},{\"start\":\"33944\",\"end\":\"33957\"},{\"start\":\"34344\",\"end\":\"34354\"},{\"start\":\"34354\",\"end\":\"34368\"},{\"start\":\"34368\",\"end\":\"34377\"},{\"start\":\"34377\",\"end\":\"34389\"},{\"start\":\"34389\",\"end\":\"34401\"},{\"start\":\"34401\",\"end\":\"34410\"},{\"start\":\"34778\",\"end\":\"34790\"},{\"start\":\"34790\",\"end\":\"34798\"},{\"start\":\"34798\",\"end\":\"34805\"},{\"start\":\"34805\",\"end\":\"34815\"},{\"start\":\"34815\",\"end\":\"34827\"},{\"start\":\"35154\",\"end\":\"35168\"},{\"start\":\"35168\",\"end\":\"35187\"},{\"start\":\"35187\",\"end\":\"35200\"},{\"start\":\"35553\",\"end\":\"35565\"},{\"start\":\"35565\",\"end\":\"35574\"},{\"start\":\"35574\",\"end\":\"35582\"},{\"start\":\"35889\",\"end\":\"35896\"},{\"start\":\"35896\",\"end\":\"35902\"},{\"start\":\"35902\",\"end\":\"35910\"},{\"start\":\"36241\",\"end\":\"36250\"},{\"start\":\"36250\",\"end\":\"36259\"},{\"start\":\"36259\",\"end\":\"36267\"},{\"start\":\"36598\",\"end\":\"36607\"},{\"start\":\"36607\",\"end\":\"36617\"},{\"start\":\"36617\",\"end\":\"36626\"},{\"start\":\"36901\",\"end\":\"36912\"},{\"start\":\"36912\",\"end\":\"36921\"},{\"start\":\"36921\",\"end\":\"36933\"},{\"start\":\"36933\",\"end\":\"36944\"},{\"start\":\"37224\",\"end\":\"37231\"},{\"start\":\"37231\",\"end\":\"37241\"},{\"start\":\"37241\",\"end\":\"37252\"},{\"start\":\"37252\",\"end\":\"37261\"},{\"start\":\"37261\",\"end\":\"37272\"},{\"start\":\"37272\",\"end\":\"37283\"},{\"start\":\"37672\",\"end\":\"37681\"},{\"start\":\"37681\",\"end\":\"37691\"},{\"start\":\"37691\",\"end\":\"37701\"},{\"start\":\"38142\",\"end\":\"38153\"},{\"start\":\"38153\",\"end\":\"38167\"},{\"start\":\"38167\",\"end\":\"38177\"},{\"start\":\"38720\",\"end\":\"38729\"},{\"start\":\"38729\",\"end\":\"38738\"},{\"start\":\"38738\",\"end\":\"38749\"},{\"start\":\"38749\",\"end\":\"38759\"},{\"start\":\"38759\",\"end\":\"38770\"},{\"start\":\"38770\",\"end\":\"38781\"}]", "bib_venue": "[{\"start\":\"24669\",\"end\":\"24718\"},{\"start\":\"25050\",\"end\":\"25057\"},{\"start\":\"25362\",\"end\":\"25388\"},{\"start\":\"25674\",\"end\":\"25704\"},{\"start\":\"26017\",\"end\":\"26029\"},{\"start\":\"26355\",\"end\":\"26372\"},{\"start\":\"26668\",\"end\":\"26684\"},{\"start\":\"27065\",\"end\":\"27072\"},{\"start\":\"27470\",\"end\":\"27477\"},{\"start\":\"27761\",\"end\":\"27765\"},{\"start\":\"28052\",\"end\":\"28064\"},{\"start\":\"28379\",\"end\":\"28396\"},{\"start\":\"28738\",\"end\":\"28749\"},{\"start\":\"29129\",\"end\":\"29143\"},{\"start\":\"29460\",\"end\":\"29468\"},{\"start\":\"29624\",\"end\":\"29662\"},{\"start\":\"29854\",\"end\":\"29863\"},{\"start\":\"30178\",\"end\":\"30186\"},{\"start\":\"30503\",\"end\":\"30512\"},{\"start\":\"30818\",\"end\":\"30825\"},{\"start\":\"31209\",\"end\":\"31221\"},{\"start\":\"31585\",\"end\":\"31602\"},{\"start\":\"31995\",\"end\":\"32003\"},{\"start\":\"32448\",\"end\":\"32457\"},{\"start\":\"32784\",\"end\":\"32803\"},{\"start\":\"33137\",\"end\":\"33144\"},{\"start\":\"33543\",\"end\":\"33556\"},{\"start\":\"33957\",\"end\":\"33973\"},{\"start\":\"34410\",\"end\":\"34419\"},{\"start\":\"34827\",\"end\":\"34835\"},{\"start\":\"35200\",\"end\":\"35213\"},{\"start\":\"35582\",\"end\":\"35596\"},{\"start\":\"35910\",\"end\":\"35929\"},{\"start\":\"36267\",\"end\":\"36279\"},{\"start\":\"36626\",\"end\":\"36649\"},{\"start\":\"36944\",\"end\":\"36958\"},{\"start\":\"37283\",\"end\":\"37296\"},{\"start\":\"37701\",\"end\":\"37708\"},{\"start\":\"38177\",\"end\":\"38200\"},{\"start\":\"38491\",\"end\":\"38541\"},{\"start\":\"38781\",\"end\":\"38793\"}]"}}}, "year": 2023, "month": 12, "day": 17}